Empagliflozin and Cardiorenal Outcomes in Patients with Nonproteinuric Kidney Disease in the EMPA-REG OUTCOME Trial

Citation
Inzucchi SE, Zinman B, George J, et al. Diabetes 2019;68(Suppl 1):248-OR.